Adial Pharmaceuticals Inc – Filings and Transcripts

NASDAQ: ADIL
Share price (9/21/26): $4.40
Market cap (9/21/26): $11.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Exempt offering of securities

Ownership Filter

Coastlands Capital LP

Coastlands Capital LP

Coastlands Capital LP

Coastlands Capital LP

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Unaudited Pro Forma Condensed Financial Information

Unregistered Sales of Equity Securities

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Adiel Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC